Diazyme SARS-CoV-2 Neutralizing Antibody Assay Receives Emergency Use Authorization
07 févr. 2023 16h11 HE
|
General Atomics
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on December 6, 2022, for use of the...
Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody Test
01 avr. 2021 17h32 HE
|
General Atomics
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for its SARS-CoV-2 neutralizing antibody test. The Diazyme test is a...
Diazyme Laboratories, Inc. Receives Reissued EUA for Semi-Quantitative SARS-CoV-2 IgG Test
23 mars 2021 20h49 HE
|
General Atomics
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- Diazyme announces that it has received a reissued Emergency Use Authorization (EUA) for its Semi-Quantitative DZ-Lite SARS-CoV-2 IgG CLIA test which is...
Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test
17 août 2020 20h09 HE
|
General Atomics
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on...
Diazyme Laboratories, Inc. Announces Partnership for COVID-19 Molecular Diagnostics Test
30 juil. 2020 16h06 HE
|
General Atomics
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Diazyme announces partnership with Maccura Biotechnology (USA) LLC, launching a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. “Here at Diazyme,...
Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test
08 juil. 2020 20h32 HE
|
General Atomics
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on...
Diazyme Laboratories, Inc. Announces Availability of COVID-19 Antibody Tests
25 mars 2020 20h45 HE
|
General Atomics
SAN DIEGO, CA, March 25, 2020 (GLOBE NEWSWIRE) -- Diazyme announces the availability of two serological tests for the novel coronavirus (SARS-CoV-2), namely the Diazyme DZ-Lite SARS-CoV-2 IgG and...